Literature DB >> 26681762

Clinical and molecular genetic characterization of wild-type MLL infant acute lymphoblastic leukemia identifies few recurrent abnormalities.

Marieke H van der Linden1, Judith M Boer2, Pauline Schneider2, Merel Willekes2, Lidija Seslija2, Paola De Lorenzo3, Maria Grazia Valsecchi4, Giovanni Cazzaniga5, Andrea Biondi5, Monique L den Boer2, Rob Pieters6, Ronald W Stam2.   

Abstract

Entities:  

Keywords:  ALL; infant; wild-type MLL

Mesh：

Substances：

Year:  2015        PMID： 26681762      PMCID： PMC4815736          DOI： 10.3324/haematol.2014.122119

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  9 in total

1.  Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study.

Authors:  Huining Kang; Carla S Wilson; Richard C Harvey; I-Ming Chen; Maurice H Murphy; Susan R Atlas; Edward J Bedrick; Meenakshi Devidas; Andrew J Carroll; Blaine W Robinson; Ronald W Stam; Maria G Valsecchi; Rob Pieters; Nyla A Heerema; Joanne M Hilden; Carolyn A Felix; Gregory H Reaman; Bruce Camitta; Naomi Winick; William L Carroll; ZoAnn E Dreyer; Stephen P Hunger; Cheryl L Willman
Journal:  Blood       Date:  2011-12-30       Impact factor: 22.113

2.  Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements.

Authors:  P De Lorenzo; A V Moorman; R Pieters; Z E Dreyer; N A Heerema; A J Carroll; S P Hunger; R Harvey; C L Willman; M Devidas; M-G Valsecchi; C J Harrison
Journal:  Leukemia       Date:  2013-09-27       Impact factor: 11.528

3.  Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.

Authors:  Stephen P Hunger; Xiaomin Lu; Meenakshi Devidas; Bruce M Camitta; Paul S Gaynon; Naomi J Winick; Gregory H Reaman; William L Carroll
Journal:  J Clin Oncol       Date:  2012-03-12       Impact factor: 44.544

Review 4.  Genomic approaches to the pathogenesis and treatment of acute lymphoblastic leukemias.

Authors:  Scott A Armstrong; James J-D Hsieh; Stanley J Korsmeyer
Journal:  Curr Opin Hematol       Date:  2002-07       Impact factor: 3.284

5.  Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.

Authors:  Eng-Juh Yeoh; Mary E Ross; Sheila A Shurtleff; W Kent Williams; Divyen Patel; Rami Mahfouz; Fred G Behm; Susana C Raimondi; Mary V Relling; Anami Patel; Cheng Cheng; Dario Campana; Dawn Wilkins; Xiaodong Zhou; Jinyan Li; Huiqing Liu; Ching-Hon Pui; William E Evans; Clayton Naeve; Limsoon Wong; James R Downing
Journal:  Cancer Cell       Date:  2002-03       Impact factor: 31.743

6.  Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.

Authors:  Joanne M Hilden; Patricia A Dinndorf; Sharon O Meerbaum; Harland Sather; Doojduen Villaluna; Nyla A Heerema; Ron McGlennen; Franklin O Smith; William G Woods; Wanda L Salzer; Helen S Johnstone; Zoann Dreyer; Gregory H Reaman
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

7.  Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants.

Authors:  Ronald W Stam; Pauline Schneider; Jill A P Hagelstein; Marieke H van der Linden; Dominique J P M Stumpel; Renee X de Menezes; Paola de Lorenzo; Maria G Valsecchi; Rob Pieters
Journal:  Blood       Date:  2009-12-23       Impact factor: 22.113

8.  Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL.

Authors:  Arian van der Veer; Esmé Waanders; Rob Pieters; Marieke E Willemse; Simon V Van Reijmersdal; Lisa J Russell; Christine J Harrison; William E Evans; Vincent H J van der Velden; Peter M Hoogerbrugge; Frank Van Leeuwen; Gabriele Escherich; Martin A Horstmann; Leila Mohammadi Khankahdani; Dimitris Rizopoulos; Hester A De Groot-Kruseman; Edwin Sonneveld; Roland P Kuiper; Monique L Den Boer
Journal:  Blood       Date:  2013-08-23       Impact factor: 22.113

9.  A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

Authors:  Rob Pieters; Martin Schrappe; Paola De Lorenzo; Ian Hann; Giulio De Rossi; Maria Felice; Liisa Hovi; Thierry LeBlanc; Tomasz Szczepanski; Alice Ferster; Gritta Janka; Jeffrey Rubnitz; Lewis Silverman; Jan Stary; Myriam Campbell; Chi-Kong Li; Georg Mann; Ram Suppiah; Andrea Biondi; Ajay Vora; Maria Grazia Valsecchi
Journal:  Lancet       Date:  2007-07-21       Impact factor: 79.321
  9 in total
  3 in total

1.  The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis.

Authors:  P Garrido Castro; E H J van Roon; S S Pinhanços; L Trentin; P Schneider; M Kerstjens; G Te Kronnie; O Heidenreich; R Pieters; R W Stam
Journal:  Leukemia       Date:  2017-07-10       Impact factor: 11.528

Review 2.  Acute Leukemia in Infants.

Authors:  Azada Ibrahimova; Lauren Pommert; Erin H Breese
Journal:  Curr Oncol Rep       Date:  2021-02-12       Impact factor: 5.075

Review 3.  Role of RNF20 in cancer development and progression - a comprehensive review.

Authors:  Gautam Sethi; Muthu K Shanmugam; Frank Arfuso; Alan Prem Kumar
Journal:  Biosci Rep       Date:  2018-07-12       Impact factor: 3.840
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.